[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360198-105":59,"doc-detail-360198-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","development-and-verification-of-cell-cycle-related-gene-markers-for-prognosis-in-bladder-cancer","Development and verification of cell cycle-related gene markers for prognosis in bladder cancer","","Abnormal expression of cell cycle control–related genes drives initiation and progression of bladder cancer. Transcriptomic data from TCGA were used to identify cell cycle-related genes with differential expression between early-stage (I–II) and advanced-stage (III–IV) disease. Samples were split into training and validation cohorts, and a nine-gene LASSO-derived prognostic model was built and independently validated. High-risk patients showed worse overall survival, supported by ROC analyses, with immune and functional enrichment differences.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-and-verification-of-cell-cycle-related-gene-markers-for-prognosis-in-bladder-cancer/360198/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-and-verification-of-cell-cycle-related-gene-markers-for-prognosis-in-bladder-cancer/360198.png","ImageObject",300,407,{"name":92,"@type":93},"Terk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What genes were investigated and how were they selected?","Question",{"text":112,"@type":113},"Cell cycle-related genes were identified by analyzing TCGA transcriptomic profiles for significant expression differences between early-stage (I–II) and advanced-stage (III–IV) bladder cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the prognostic model constructed and validated?",{"text":117,"@type":113},"Identified samples were randomly divided into training and validation sets. A nine-gene prognostic model was built using LASSO regression on the training dataset and then confirmed on the validation dataset.",{"name":119,"@type":110,"acceptedAnswer":120},"What prognostic differences were observed between risk groups?",{"text":121,"@type":113},"Patients in the high-risk group had substantially worse overall survival, and the model’s predictive performance was further supported by ROC curve analyses.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360198,1790518599,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Development and veriﬁcation of cell cycle-related gene markers for prognosis in bladder cancer  \nHao Li 1  and Dandan Zhu2  \nCancer Biomarkers Vol. 43(0): 1–14 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/18758592261449024](DOI: 10.1177/18758592261449024)[ ](DOI: 10.1177/18758592261449024)[journals.sagepub.com/home/cbm](journals.sagepub.com/home/cbm)  \nAbstract  \nBackground: The abnormal expression patterns of genes associated with cell cycle control are essential contributors to the initiation and progression of bladder cancer (BC).  \nMethods: In this research, transcriptomic proﬁles sourced from The Cancer Genome Atlas (TCGA) were examined to pinpoint cell cycle-related genes with signiﬁcant expression differences between early-stage (I–II) and advanced-stage (III–IV) BC. The identiﬁed BC samples were then randomly split into training and validation groups. A prognostic model containing nine key genes was subsequently constructed from the training dataset using the least absolute shrinkage and selection operator (LASSO) regression algorithm, and its predictive reliability was independently conﬁrmed in the validation dataset. Based on individual risk scores derived from this gene signature, patients were separated into high- and low-risk groups. Functional enrichment analyses (GO and KEGG), immune cell inﬁltration (CIBERSORT), and gene set variation analysis (GSVA) were performed to explore the biological functions and immune landscape associated with the risk signature.  \nResults: Survival analysis revealed substantially worse overall survival (OS) in patients categorized as high-risk. The prognostic efﬁcacy of the constructed gene signature was further corroborated by receiver operating characteristic (ROC) curve analyses. Functional enrichment analyses revealed that these genes were chieﬂy associated with critical biological processes such as cellular differentiation, proliferation, and migration, involving key signaling pathways like PI3K-Akt signaling, positive modulation of the MAPK cascade, and cell-matrix interactions. Immune inﬁltration analysis showed that tumors from patients in the high-risk group had increased inﬁltration by M2 macrophages. Furthermore, GSVA results indicated that stromal and angiogenic functions were enriched in the high-risk group.  \nConclusions: These results highlight the potential clinical utility of the newly developed cell cycle-associated gene signature, providing effective biomarkers to facilitate personalized therapeutic decision-making for BC patients.  \nKeywords  \nbladder cancer, survival, cell cycle, tumor microenvironment, immune inﬁltration  \nReceived: 26 August 2025; accepted: 22 April 2026  \nIntroduction  \nBC, ranked tenth among malignancies globally, constitutes a notable proportion of cancers involving the urinary tract. In 2022, bladder cancer remained a signiﬁcant global health burden, with an estimated 613,791 new cases and 220,349 deaths.1 Epidemiological data demonstrate a marked gender discrepancy, with males exhibiting incidence rates roughly three to four times higher than females, a phenomenon closely associated with speciﬁc risk factors, such as tobacco use and exposure to carcinogenic agents (especially aromatic amines) . Currently acknowledged risk factors encompass cigarette smoking (contributing to 55.1% of BC cases), obesity characterized by elevated body mass index (BMI), occupational exposure to carcinogens, and  \npersistent inﬂammation of the bladder (chronic cystitis) .2 Treatment modalities are primarily selected based upon clinical staging; transurethral resection of bladder tumor  \n1 Department of Urology, General Hospital of Xuzhou Mining Group (The second Afﬁliated Hospital of Xuzhou Medical University), Xuzhou, China, 2Department of Traditional Chinese Medicine, General Hospital of Xuzhou Mining Group (The second Afﬁliated Hospital ","cbCaipJxStSHnR8d","https://ap.wps.com/l/cbCaipJxStSHnR8d","pdf",4172488,14,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Epidemiology and risk factors\n## Current treatment strategies and prognosis context","[{\"question\":\"What genes were investigated and how were they selected?\",\"answer\":\"Cell cycle-related genes were identified by analyzing TCGA transcriptomic profiles for significant expression differences between early-stage (I–II) and advanced-stage (III–IV) bladder cancer.\"},{\"question\":\"How was the prognostic model constructed and validated?\",\"answer\":\"Identified samples were randomly divided into training and validation sets. A nine-gene prognostic model was built using LASSO regression on the training dataset and then confirmed on the validation dataset.\"},{\"question\":\"What prognostic differences were observed between risk groups?\",\"answer\":\"Patients in the high-risk group had substantially worse overall survival, and the model’s predictive performance was further supported by ROC curve analyses.\"}]","Development and verification of cell cycle-related gene markers for prognosis in bladder cancer | PDF",1790139045,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3dd7ce917216c14244f3cd71df0ce31e.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/15a4c804152f754bab9f32dd9583c926.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c391cf9cf325fe26bf201e230efa242a.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9cca7810da15a4493267073df6c00928.webp",980,1306]